Terry L. Murdock, SVP of Development Operations at G1 Therapeutics, Inc. (GTHX), sold 7,038 shares at $41.53 ($292K) on 2018-11-05, disclosed to the SEC on 2018-11-07.
Open-market sale of $292k GTHX by SVP of Development Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.53 | 3,519 | $146K | 50.0% |
| 2 | $41.53 | 3,519 | $146K | 50.0% |
| Total | $41.53 avg | 7,038 | $292K | 100% |
| Filing → |
| GTHX | SELL | 2024-01-08 | $12K | — | Filing → |
| GTHX | SELL | 2023-07-07 | $3K | — | Filing → |
| GTHX | SELL | 2023-01-05 | $13K | — | Filing → |